| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.3B | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $1.23 | $1.34 | $1.79 | $1.78 | $1.48 | $1.29 | $1.18 | $0.82 |
| EPS (Diluted) | $1.22 | $1.33 | $0.39 | $0.18 | $0.40 | $1.28 | $1.16 | $0.82 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.1B | $5.1B | $4.1B | $4.1B | $3.1B | $2.4B | $2.3B | $2.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $4.7B | $4.7B | $3.8B | $3.7B | $2.7B | $2.1B | $2.1B | $1.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.4B | $0.4B | $0.3B | $0.5B | $0.4B | $0.3B | $0.3B | $0.2B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | — |
| Investing Cash Flow | $-0.1B | $0.1B | $-0.2B | $-0.4B | $-0.2B | $-0.1B | $-0.2B | — |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.0B | $-0.1B | $0.1B | $0.2B | $0.3B | $0.1B | $0.1B | — |